News by Tag: Biopharmaceutical Market
Entry of Biosimilars will Expand the Demand of Cold Chain Logistic Services
November 29, 2011
A New Report from IMARC Group expects the growth of the biosimilar market to expand the demand of cold chain logistic services in the coming years.
November 29, 2011
A New Report from IMARC Group expects the growth of the biosimilar market to expand the demand of cold chain logistic services in the coming years.
The Market for Biopharmaceuticals was Worth USD 101 Billion in 2010
August 1, 2011
A new report from IMARC Group expects that driven by factors such as a strong pipeline and ability to treat diseases with high unmet needs, the global market for biopharmaceuticals is expected to reach revenues worth US$ 167 Billion by 2015.
August 1, 2011
A new report from IMARC Group expects that driven by factors such as a strong pipeline and ability to treat diseases with high unmet needs, the global market for biopharmaceuticals is expected to reach revenues worth US$ 167 Billion by 2015.
Emerging Biopharmaceutical Markets to Exceed US$ 13.6 Billion by 2015
June 14, 2011
IMARC Group, one of the world's leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015.
June 14, 2011
IMARC Group, one of the world's leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015.
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing
April 29, 2011
This report provides the key to market data on overall upstream process, Contract Manufacturing Organization (CMO) market for upstream processing, and the cell culture and reagent market.
April 29, 2011
This report provides the key to market data on overall upstream process, Contract Manufacturing Organization (CMO) market for upstream processing, and the cell culture and reagent market.